Caveolin-1 promotes tumor growth and metastasis via autophagy inhibition in hepatocellular carcinoma

Caveolin-1 is a member of the caveolae family of membrane proteins. Although some researchers have investigated the function of Caveolin-1 in hepatocellular carcinoma, the mechanism of Caveolin-1 action and its prognostic value in hepatocellular carcinoma remain unclear. Caveolin-1 expression was me...

Full description

Saved in:
Bibliographic Details
Published inClinics and research in hepatology and gastroenterology Vol. 40; no. 2; pp. 169 - 178
Main Authors Liu, Wei-Ren, Jin, Lei, Tian, Meng-Xin, Jiang, Xi-Fei, Yang, Liu-Xiao, Ding, Zhen-Bin, Shen, Ying-Hao, Peng, Yuan-Fei, Gao, Dong-Mei, Zhou, Jian, Qiu, Shuang-Jian, Dai, Zhi, Fan, Jia, Shi, Ying-Hong
Format Journal Article
LanguageEnglish
Published France Elsevier Masson SAS 01.04.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Caveolin-1 is a member of the caveolae family of membrane proteins. Although some researchers have investigated the function of Caveolin-1 in hepatocellular carcinoma, the mechanism of Caveolin-1 action and its prognostic value in hepatocellular carcinoma remain unclear. Caveolin-1 expression was measured in hepatocellular carcinoma cell lines and tissues using quantitative reverse transcription-polymerase chain reaction, western blot, and immunofluorescence assays. In in vitro experiments, Caveolin-1 was depleted using a short hairpin RNA lentiviral vector, and tumor cell behavior was analyzed. The effect of Caveolin-1 on hepatocellular carcinoma cell autophagy was investigated. Prognostic value of Caveolin-1 was analyzed by immunohistochemistry in two cohorts that included a total of 721 hepatocellular carcinoma patients. We found that Caveolin-1 was overexpressed in highly metastatic hepatocellular carcinoma cell lines and tumor tissues. Moreover, Caveolin-1 promoted hepatocellular carcinoma cell proliferation, migration, and angiogenesis and inhibited autophagy. Finally, Caveolin-1 expression in hepatocellular carcinoma tissues was inversely correlated with patient overall survival and time to recurrence. Our data obtained from cell lines suggest an oncogenic role for Caveolin-1 in hepatocellular carcinoma, Caveolin-1 contributed to hepatocellular carcinoma cell autophagy deficiency. Furthermore, Caveolin-1 may function as a novel prognostic indicator for hepatocellular carcinoma patients after curative resection, and combination of targeted therapy aimed at Caveolin-1 and autophagy modulation may represent an effective way to treat hepatocellular carcinoma.
AbstractList Summary Background Caveolin-1 is a member of the caveolae family of membrane proteins. Although some researchers have investigated the function of Caveolin-1 in hepatocellular carcinoma, the mechanism of Caveolin-1 action and its prognostic value in hepatocellular carcinoma remain unclear. Methods Caveolin-1 expression was measured in hepatocellular carcinoma cell lines and tissues using quantitative reverse transcription-polymerase chain reaction, western blot, and immunofluorescence assays. In in vitro experiments, Caveolin-1 was depleted using a short hairpin RNA lentiviral vector, and tumor cell behavior was analyzed. The effect of Caveolin-1 on hepatocellular carcinoma cell autophagy was investigated. Prognostic value of Caveolin-1 was analyzed by immunohistochemistry in two cohorts that included a total of 721 hepatocellular carcinoma patients. Results We found that Caveolin-1 was overexpressed in highly metastatic hepatocellular carcinoma cell lines and tumor tissues. Moreover, Caveolin-1 promoted hepatocellular carcinoma cell proliferation, migration, and angiogenesis and inhibited autophagy. Finally, Caveolin-1 expression in hepatocellular carcinoma tissues was inversely correlated with patient overall survival and time to recurrence. Conclusion Our data obtained from cell lines suggest an oncogenic role for Caveolin-1 in hepatocellular carcinoma, Caveolin-1 contributed to hepatocellular carcinoma cell autophagy deficiency. Furthermore, Caveolin-1 may function as a novel prognostic indicator for hepatocellular carcinoma patients after curative resection, and combination of targeted therapy aimed at Caveolin-1 and autophagy modulation may represent an effective way to treat hepatocellular carcinoma.
Caveolin-1 is a member of the caveolae family of membrane proteins. Although some researchers have investigated the function of Caveolin-1 in hepatocellular carcinoma, the mechanism of Caveolin-1 action and its prognostic value in hepatocellular carcinoma remain unclear. Caveolin-1 expression was measured in hepatocellular carcinoma cell lines and tissues using quantitative reverse transcription-polymerase chain reaction, western blot, and immunofluorescence assays. In in vitro experiments, Caveolin-1 was depleted using a short hairpin RNA lentiviral vector, and tumor cell behavior was analyzed. The effect of Caveolin-1 on hepatocellular carcinoma cell autophagy was investigated. Prognostic value of Caveolin-1 was analyzed by immunohistochemistry in two cohorts that included a total of 721 hepatocellular carcinoma patients. We found that Caveolin-1 was overexpressed in highly metastatic hepatocellular carcinoma cell lines and tumor tissues. Moreover, Caveolin-1 promoted hepatocellular carcinoma cell proliferation, migration, and angiogenesis and inhibited autophagy. Finally, Caveolin-1 expression in hepatocellular carcinoma tissues was inversely correlated with patient overall survival and time to recurrence. Our data obtained from cell lines suggest an oncogenic role for Caveolin-1 in hepatocellular carcinoma, Caveolin-1 contributed to hepatocellular carcinoma cell autophagy deficiency. Furthermore, Caveolin-1 may function as a novel prognostic indicator for hepatocellular carcinoma patients after curative resection, and combination of targeted therapy aimed at Caveolin-1 and autophagy modulation may represent an effective way to treat hepatocellular carcinoma.
Caveolin-1 is a member of the caveolae family of membrane proteins. Although some researchers have investigated the function of Caveolin-1 in hepatocellular carcinoma, the mechanism of Caveolin-1 action and its prognostic value in hepatocellular carcinoma remain unclear.BACKGROUNDCaveolin-1 is a member of the caveolae family of membrane proteins. Although some researchers have investigated the function of Caveolin-1 in hepatocellular carcinoma, the mechanism of Caveolin-1 action and its prognostic value in hepatocellular carcinoma remain unclear.Caveolin-1 expression was measured in hepatocellular carcinoma cell lines and tissues using quantitative reverse transcription-polymerase chain reaction, western blot, and immunofluorescence assays. In in vitro experiments, Caveolin-1 was depleted using a short hairpin RNA lentiviral vector, and tumor cell behavior was analyzed. The effect of Caveolin-1 on hepatocellular carcinoma cell autophagy was investigated. Prognostic value of Caveolin-1 was analyzed by immunohistochemistry in two cohorts that included a total of 721 hepatocellular carcinoma patients.METHODSCaveolin-1 expression was measured in hepatocellular carcinoma cell lines and tissues using quantitative reverse transcription-polymerase chain reaction, western blot, and immunofluorescence assays. In in vitro experiments, Caveolin-1 was depleted using a short hairpin RNA lentiviral vector, and tumor cell behavior was analyzed. The effect of Caveolin-1 on hepatocellular carcinoma cell autophagy was investigated. Prognostic value of Caveolin-1 was analyzed by immunohistochemistry in two cohorts that included a total of 721 hepatocellular carcinoma patients.We found that Caveolin-1 was overexpressed in highly metastatic hepatocellular carcinoma cell lines and tumor tissues. Moreover, Caveolin-1 promoted hepatocellular carcinoma cell proliferation, migration, and angiogenesis and inhibited autophagy. Finally, Caveolin-1 expression in hepatocellular carcinoma tissues was inversely correlated with patient overall survival and time to recurrence.RESULTSWe found that Caveolin-1 was overexpressed in highly metastatic hepatocellular carcinoma cell lines and tumor tissues. Moreover, Caveolin-1 promoted hepatocellular carcinoma cell proliferation, migration, and angiogenesis and inhibited autophagy. Finally, Caveolin-1 expression in hepatocellular carcinoma tissues was inversely correlated with patient overall survival and time to recurrence.Our data obtained from cell lines suggest an oncogenic role for Caveolin-1 in hepatocellular carcinoma, Caveolin-1 contributed to hepatocellular carcinoma cell autophagy deficiency. Furthermore, Caveolin-1 may function as a novel prognostic indicator for hepatocellular carcinoma patients after curative resection, and combination of targeted therapy aimed at Caveolin-1 and autophagy modulation may represent an effective way to treat hepatocellular carcinoma.CONCLUSIONOur data obtained from cell lines suggest an oncogenic role for Caveolin-1 in hepatocellular carcinoma, Caveolin-1 contributed to hepatocellular carcinoma cell autophagy deficiency. Furthermore, Caveolin-1 may function as a novel prognostic indicator for hepatocellular carcinoma patients after curative resection, and combination of targeted therapy aimed at Caveolin-1 and autophagy modulation may represent an effective way to treat hepatocellular carcinoma.
Author Zhou, Jian
Jiang, Xi-Fei
Fan, Jia
Liu, Wei-Ren
Gao, Dong-Mei
Dai, Zhi
Yang, Liu-Xiao
Qiu, Shuang-Jian
Shi, Ying-Hong
Peng, Yuan-Fei
Jin, Lei
Tian, Meng-Xin
Shen, Ying-Hao
Ding, Zhen-Bin
Author_xml – sequence: 1
  givenname: Wei-Ren
  surname: Liu
  fullname: Liu, Wei-Ren
  organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China
– sequence: 2
  givenname: Lei
  surname: Jin
  fullname: Jin, Lei
  organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China
– sequence: 3
  givenname: Meng-Xin
  surname: Tian
  fullname: Tian, Meng-Xin
  organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China
– sequence: 4
  givenname: Xi-Fei
  surname: Jiang
  fullname: Jiang, Xi-Fei
  organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China
– sequence: 5
  givenname: Liu-Xiao
  surname: Yang
  fullname: Yang, Liu-Xiao
  organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China
– sequence: 6
  givenname: Zhen-Bin
  surname: Ding
  fullname: Ding, Zhen-Bin
  organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China
– sequence: 7
  givenname: Ying-Hao
  surname: Shen
  fullname: Shen, Ying-Hao
  organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China
– sequence: 8
  givenname: Yuan-Fei
  surname: Peng
  fullname: Peng, Yuan-Fei
  organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China
– sequence: 9
  givenname: Dong-Mei
  surname: Gao
  fullname: Gao, Dong-Mei
  organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China
– sequence: 10
  givenname: Jian
  surname: Zhou
  fullname: Zhou, Jian
  organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China
– sequence: 11
  givenname: Shuang-Jian
  surname: Qiu
  fullname: Qiu, Shuang-Jian
  organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China
– sequence: 12
  givenname: Zhi
  surname: Dai
  fullname: Dai, Zhi
  organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China
– sequence: 13
  givenname: Jia
  surname: Fan
  fullname: Fan, Jia
  organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China
– sequence: 14
  givenname: Ying-Hong
  surname: Shi
  fullname: Shi, Ying-Hong
  email: shi.yinghong@zs-hospital.sh.cn
  organization: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180, FengLin Road, 200032 Shanghai, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26206578$$D View this record in MEDLINE/PubMed
BookMark eNqFkV9rFDEUxYNUbK39BiJ59GXGm8xkMisiyOI_KPjQCr6FTHKnm3VmsiaZlf32Zrq1D4VqCOQ-nPNLcs5zcjL5CQl5yaBkwJo329IMbgpYcmCihKYEJp-QM84ZFLJmP07uZ2Cn5CLGLeRVC2gle0ZOecOhEbI9I3at9-gzq2B0F_zoE0aa5tEHehP877SherJ0xKRj3i7SvdNUz8nvNvrmQN20cZ1Lzk95pBvc6eQNDsM86ECNDsZNftQvyNNeDxEv7s5z8v3Tx-v1l-Ly2-ev6w-XhalbloqOc9EYbG0vVi1gbbq-NrYB5J1E0fdoq1WLwpqOdRzQVKKyohF1y-3Kauyqc_L6yM0_-TVjTGp0cXmOntDPUTEpWwmSM5mlr-6kczeiVbvgRh0O6m8yWVAfBSb4GAP29xIGaulAbdWxA7V0oKBRcMt9-8BmXNJLQCloN_zP_P5oxhzS3mG4FTmjh594wLj1c5hyfoqpyBWoq6XipWEmIFOqVQa8exygrHf_vv8PzPK64A
CitedBy_id crossref_primary_10_1016_j_atherosclerosis_2025_119113
crossref_primary_10_1097_MD_0000000000007359
crossref_primary_10_3390_ijms21114171
crossref_primary_10_1002_ijc_31369
crossref_primary_10_2147_CMAR_S264673
crossref_primary_10_1186_s12943_016_0558_7
crossref_primary_10_1111_eci_14065
crossref_primary_10_1186_s12964_023_01053_z
crossref_primary_10_1016_j_omto_2021_10_005
crossref_primary_10_1016_j_yexcr_2017_07_004
crossref_primary_10_3389_fphar_2023_1237456
crossref_primary_10_1038_s41419_018_0795_3
crossref_primary_10_1063_1_5024386
crossref_primary_10_1007_s00232_020_00160_z
crossref_primary_10_1007_s10555_020_09890_x
crossref_primary_10_3390_cells9020367
crossref_primary_10_1093_carcin_bgab080
crossref_primary_10_1111_cas_13659
crossref_primary_10_1007_s11010_017_3003_3
crossref_primary_10_1007_s10719_021_09998_4
crossref_primary_10_2147_IJN_S282172
crossref_primary_10_3390_biom9080314
crossref_primary_10_3390_molecules24203651
crossref_primary_10_3892_etm_2017_5038
crossref_primary_10_1016_j_cca_2020_11_020
crossref_primary_10_3389_fphys_2019_01606
crossref_primary_10_1080_14756366_2023_2288806
Cites_doi 10.3322/caac.20107
10.1158/0008-5472.CAN-11-3102
10.1038/nm843
10.4161/cc.10.24.18551
10.1002/hep.22393
10.4161/cc.9.21.13817
10.1016/j.biocel.2011.01.023
10.1007/s00432-004-0564-9
10.1158/0008-5472.CAN-12-0777
10.1158/0008-5472.CAN-10-4249
10.4161/auto.7.10.16818
10.1016/j.bbrc.2006.03.246
10.1158/1078-0432.CCR-12-0183
10.1146/annurev-pathol-011811-120856
10.3389/fphys.2011.00120
10.1016/j.cell.2011.05.040
10.1038/onc.2011.154
10.1158/0008-5472.CAN-12-0448
10.1016/S0140-6736(11)61347-0
10.1016/j.febslet.2013.02.002
10.1007/s12032-011-9900-5
10.1016/j.ejca.2013.08.016
10.1158/0008-5472.CAN-12-3040
10.1016/S1937-6448(08)01804-2
10.3109/00313025.2010.494293
10.1002/path.3957
10.1200/JCO.2006.09.4565
10.1186/1471-2407-9-65
10.1056/NEJMcibr1114526
ContentType Journal Article
Copyright 2015 Elsevier Masson SAS
Elsevier Masson SAS
Copyright © 2015 Elsevier Masson SAS. All rights reserved.
Copyright_xml – notice: 2015 Elsevier Masson SAS
– notice: Elsevier Masson SAS
– notice: Copyright © 2015 Elsevier Masson SAS. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.clinre.2015.06.017
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2210-741X
EndPage 178
ExternalDocumentID 26206578
10_1016_j_clinre_2015_06_017
1_s2_0_S2210740115001539
S2210740115001539
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID --M
.1-
.55
.FO
.~1
08J
08T
0R~
1P~
1~.
4.4
457
4G.
53G
5VS
7-5
8P~
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AATTM
AAXKI
AAXUO
AAYWO
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AXJTR
BKOJK
BLXMC
BNPGV
EBS
EFJIC
EFKBS
EJD
F5P
FDB
FIRID
FNPLU
FYGXN
GBLVA
HZ~
J1W
KOM
MO0
O-L
O9-
OAUVE
OC.
ON0
P-8
P-9
PC.
Q38
ROL
SDF
SEM
SES
SPCBC
SSH
SSZ
T5K
X7M
Z5R
~G-
AACTN
AFKWA
AJOXV
AMFUW
RIG
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c481t-b2256ce8df5980e4cbf4cd60e2b7e5ffed398e5dcb1b20ec353d565482d9daeb3
ISSN 2210-7401
2210-741X
IngestDate Fri Jul 11 08:53:44 EDT 2025
Mon Jul 21 05:59:33 EDT 2025
Thu Apr 24 22:59:23 EDT 2025
Tue Jul 01 00:58:37 EDT 2025
Tue Feb 25 19:56:02 EST 2025
Tue Aug 26 16:39:12 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Cav-1
TNM
TTR
OS
CI
qRT-PCR
γ-GT
HCC
TMA
HR
AFP
EMT
Caveolin-1
Quantitative reverse transcription-polymerase chain reaction
Confidential interval
Hepatocellular carcinoma
Time to recurrence
Tissue microarray
Hazard ratio
Epithelial-to-mesenchymal transition
γ-glutamyl transferase
α-fetoprotein
Overall survival
Tumor-nodes-metastasis
Language English
License Copyright © 2015 Elsevier Masson SAS. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c481t-b2256ce8df5980e4cbf4cd60e2b7e5ffed398e5dcb1b20ec353d565482d9daeb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 26206578
PQID 1778707217
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_1778707217
pubmed_primary_26206578
crossref_primary_10_1016_j_clinre_2015_06_017
crossref_citationtrail_10_1016_j_clinre_2015_06_017
elsevier_clinicalkeyesjournals_1_s2_0_S2210740115001539
elsevier_clinicalkey_doi_10_1016_j_clinre_2015_06_017
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-04-01
PublicationDateYYYYMMDD 2016-04-01
PublicationDate_xml – month: 04
  year: 2016
  text: 2016-04-01
  day: 01
PublicationDecade 2010
PublicationPlace France
PublicationPlace_xml – name: France
PublicationTitle Clinics and research in hepatology and gastroenterology
PublicationTitleAlternate Clin Res Hepatol Gastroenterol
PublicationYear 2016
Publisher Elsevier Masson SAS
Publisher_xml – name: Elsevier Masson SAS
References Gao, Qiu, Fan, Zhou, Wang, Xiao (bib0240) 2007; 25
Huang, Ding, Gu, Zhou, Kuang, Ji (bib0250) 2012; 18
Yu, Fan, Liu, Zhang, Wang, Zhang (bib0195) 2013; 587
Wu, Queenan, Brody, Potoczek, Sotgia, Lisanti (bib0185) 2011; 10
Chiu, Lee, Huang, Aldape, Yao, Steeg (bib0190) 2011; 71
Yang, Yang, Huang, Wang, Lu, Tsai (bib0215) 2010; 42
Jemal, Bray, Center, Ferlay, Ward, Forman (bib0150) 2011; 61
Du, Qian, Papageorge, Schetter, Vass, Liu (bib0205) 2012; 72
Zhou, Jia, Wang, Wang, Chu, Hu (bib0255) 2006; 345
Tahir, Yang, Goltsov, Song, Ren, Wang (bib0175) 2013; 73
Martinez-Outschoorn, Whitaker-Menezes, Pavlides, Chiavarina, Bonuccelli, Casey (bib0285) 2010; 9
Forner, Llovet, Bruix (bib0155) 2012; 379
Tse, Ko, Tung, Chan, Lee, Ngan (bib0200) 2012; 226
Kannan, Krishnan, Ali, Subramaniam, Halagowder, Sivasithamparam (bib0170) 2014; 50
Ha, Her, Lee, Ryu, Lee, Han (bib0270) 2012; 72
Li, Tian, Yang, Zhao, Wu, Ye (bib0220) 2004; 130
Martinez-Outschoorn, Pavlides, Howell, Pestell, Tanowitz, Sotgia (bib0280) 2011; 43
Cokakli, Erdal, Nart, Yilmaz, Sagol, Kilic (bib0260) 2009; 9
Shi, Ding, Zhou, He, Xu, Gambotto (bib0245) 2008; 48
Sotgia, Martinez-Outschoorn, Howell, Pestell, Pavlides, Lisanti (bib0275) 2012; 7
Tang, Zeng, He, Liao, Qian, Toi (bib0210) 2012; 29
Ye, Qin, Forgues, He, Kim, Peng (bib0225) 2003; 9
Parat (bib0165) 2009; 273
Goetz, Minguet, Navarro-Lerida, Lazcano, Samaniego, Calvo (bib0290) 2011; 146
Sowa (bib0160) 2012; 2
Weiner, Lotze (bib0265) 2012; 366
Shi, Ding, Zhou, Hui, Shi, Ke (bib0230) 2011; 7
Huang, Qiu, Wang, Peng, Jia, Logsdon (bib0180) 2012; 72
Jiang, Liu, Guo, Zhang, Zhi, Ji (bib0235) 2011; 30
Tahir (10.1016/j.clinre.2015.06.017_bib0175) 2013; 73
Jemal (10.1016/j.clinre.2015.06.017_bib0150) 2011; 61
Ye (10.1016/j.clinre.2015.06.017_bib0225) 2003; 9
Zhou (10.1016/j.clinre.2015.06.017_bib0255) 2006; 345
Li (10.1016/j.clinre.2015.06.017_bib0220) 2004; 130
Cokakli (10.1016/j.clinre.2015.06.017_bib0260) 2009; 9
Sotgia (10.1016/j.clinre.2015.06.017_bib0275) 2012; 7
Shi (10.1016/j.clinre.2015.06.017_bib0230) 2011; 7
Parat (10.1016/j.clinre.2015.06.017_bib0165) 2009; 273
Gao (10.1016/j.clinre.2015.06.017_bib0240) 2007; 25
Forner (10.1016/j.clinre.2015.06.017_bib0155) 2012; 379
Sowa (10.1016/j.clinre.2015.06.017_bib0160) 2012; 2
Ha (10.1016/j.clinre.2015.06.017_bib0270) 2012; 72
Huang (10.1016/j.clinre.2015.06.017_bib0250) 2012; 18
Chiu (10.1016/j.clinre.2015.06.017_bib0190) 2011; 71
Du (10.1016/j.clinre.2015.06.017_bib0205) 2012; 72
Tse (10.1016/j.clinre.2015.06.017_bib0200) 2012; 226
Yu (10.1016/j.clinre.2015.06.017_bib0195) 2013; 587
Yang (10.1016/j.clinre.2015.06.017_bib0215) 2010; 42
Shi (10.1016/j.clinre.2015.06.017_bib0245) 2008; 48
Goetz (10.1016/j.clinre.2015.06.017_bib0290) 2011; 146
Tang (10.1016/j.clinre.2015.06.017_bib0210) 2012; 29
Martinez-Outschoorn (10.1016/j.clinre.2015.06.017_bib0285) 2010; 9
Huang (10.1016/j.clinre.2015.06.017_bib0180) 2012; 72
Jiang (10.1016/j.clinre.2015.06.017_bib0235) 2011; 30
Weiner (10.1016/j.clinre.2015.06.017_bib0265) 2012; 366
Kannan (10.1016/j.clinre.2015.06.017_bib0170) 2014; 50
Wu (10.1016/j.clinre.2015.06.017_bib0185) 2011; 10
Martinez-Outschoorn (10.1016/j.clinre.2015.06.017_bib0280) 2011; 43
References_xml – volume: 48
  start-page: 497
  year: 2008
  end-page: 507
  ident: bib0245
  article-title: Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence
  publication-title: Hepatology
– volume: 43
  start-page: 1045
  year: 2011
  end-page: 1051
  ident: bib0280
  article-title: Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment
  publication-title: Int J Biochem Cell Biol
– volume: 18
  start-page: 3042
  year: 2012
  end-page: 3053
  ident: bib0250
  article-title: Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1alpha to promote hepatocellular carcinoma invasiveness
  publication-title: Clin Cancer Res
– volume: 9
  start-page: 65
  year: 2009
  ident: bib0260
  article-title: Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion
  publication-title: BMC Cancer
– volume: 7
  start-page: 423
  year: 2012
  end-page: 467
  ident: bib0275
  article-title: Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms
  publication-title: Annu Rev Pathol
– volume: 61
  start-page: 69
  year: 2011
  end-page: 90
  ident: bib0150
  article-title: Global cancer statistics
  publication-title: CA Cancer J Clin
– volume: 587
  start-page: 782
  year: 2013
  end-page: 787
  ident: bib0195
  article-title: Caveolin-1 up-regulates integrin alpha2,6-sialylation to promote integrin alpha5beta1-dependent hepatocarcinoma cell adhesion
  publication-title: FEBS Lett
– volume: 50
  start-page: 204
  year: 2014
  end-page: 215
  ident: bib0170
  article-title: Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic condition
  publication-title: Eur J Cancer
– volume: 73
  start-page: 1900
  year: 2013
  end-page: 1911
  ident: bib0175
  article-title: Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer
  publication-title: Cancer Res
– volume: 146
  start-page: 148
  year: 2011
  end-page: 163
  ident: bib0290
  article-title: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis
  publication-title: Cell
– volume: 9
  start-page: 4297
  year: 2010
  end-page: 4306
  ident: bib0285
  article-title: The autophagic tumor stroma model of cancer or “battery-operated tumor growth”: a simple solution to the autophagy paradox
  publication-title: Cell Cycle
– volume: 42
  start-page: 438
  year: 2010
  end-page: 445
  ident: bib0215
  article-title: Increased caveolin-1 expression associated with prolonged overall survival rate in hepatocellular carcinoma
  publication-title: Pathology
– volume: 72
  start-page: 4405
  year: 2012
  end-page: 4416
  ident: bib0205
  article-title: Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells
  publication-title: Cancer Res
– volume: 25
  start-page: 2586
  year: 2007
  end-page: 2593
  ident: bib0240
  article-title: Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
  publication-title: J Clin Oncol
– volume: 366
  start-page: 1156
  year: 2012
  end-page: 1158
  ident: bib0265
  article-title: Tumor-cell death, autophagy, and immunity
  publication-title: N Engl J Med
– volume: 72
  start-page: 4097
  year: 2012
  end-page: 4109
  ident: bib0270
  article-title: Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription
  publication-title: Cancer Res
– volume: 72
  start-page: 655
  year: 2012
  end-page: 665
  ident: bib0180
  article-title: A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis
  publication-title: Cancer Res
– volume: 10
  start-page: 4250
  year: 2011
  end-page: 4255
  ident: bib0185
  article-title: Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival
  publication-title: Cell Cycle
– volume: 345
  start-page: 486
  year: 2006
  end-page: 494
  ident: bib0255
  article-title: Divergent expression and roles for caveolin-1 in mouse hepatocarcinoma cell lines with varying invasive ability
  publication-title: Biochem Biophys Res Commun
– volume: 71
  start-page: 4932
  year: 2011
  end-page: 4943
  ident: bib0190
  article-title: Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition
  publication-title: Cancer Res
– volume: 130
  start-page: 460
  year: 2004
  end-page: 468
  ident: bib0220
  article-title: Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics
  publication-title: J Cancer Res Clin Oncol
– volume: 379
  start-page: 1245
  year: 2012
  end-page: 1255
  ident: bib0155
  article-title: Hepatocellular carcinoma
  publication-title: Lancet
– volume: 226
  start-page: 645
  year: 2012
  end-page: 653
  ident: bib0200
  article-title: Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis
  publication-title: J Pathol
– volume: 7
  start-page: 1159
  year: 2011
  end-page: 1172
  ident: bib0230
  article-title: Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis
  publication-title: Autophagy
– volume: 9
  start-page: 416
  year: 2003
  end-page: 423
  ident: bib0225
  article-title: Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning
  publication-title: Nat Med
– volume: 2
  start-page: 120
  year: 2012
  ident: bib0160
  article-title: Caveolae, caveolins, cavins, and endothelial cell function: new insights
  publication-title: Front Physiol
– volume: 273
  start-page: 117
  year: 2009
  end-page: 162
  ident: bib0165
  article-title: The biology of caveolae: achievements and perspectives
  publication-title: Int Rev Cell Mol Biol
– volume: 30
  start-page: 4498
  year: 2011
  end-page: 4508
  ident: bib0235
  article-title: IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer
  publication-title: Oncogene
– volume: 29
  start-page: 977
  year: 2012
  end-page: 984
  ident: bib0210
  article-title: Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer
  publication-title: Med Oncol
– volume: 61
  start-page: 69
  year: 2011
  ident: 10.1016/j.clinre.2015.06.017_bib0150
  article-title: Global cancer statistics
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.20107
– volume: 72
  start-page: 655
  year: 2012
  ident: 10.1016/j.clinre.2015.06.017_bib0180
  article-title: A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-11-3102
– volume: 9
  start-page: 416
  year: 2003
  ident: 10.1016/j.clinre.2015.06.017_bib0225
  article-title: Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning
  publication-title: Nat Med
  doi: 10.1038/nm843
– volume: 10
  start-page: 4250
  year: 2011
  ident: 10.1016/j.clinre.2015.06.017_bib0185
  article-title: Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival
  publication-title: Cell Cycle
  doi: 10.4161/cc.10.24.18551
– volume: 48
  start-page: 497
  year: 2008
  ident: 10.1016/j.clinre.2015.06.017_bib0245
  article-title: Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence
  publication-title: Hepatology
  doi: 10.1002/hep.22393
– volume: 9
  start-page: 4297
  year: 2010
  ident: 10.1016/j.clinre.2015.06.017_bib0285
  article-title: The autophagic tumor stroma model of cancer or “battery-operated tumor growth”: a simple solution to the autophagy paradox
  publication-title: Cell Cycle
  doi: 10.4161/cc.9.21.13817
– volume: 43
  start-page: 1045
  year: 2011
  ident: 10.1016/j.clinre.2015.06.017_bib0280
  article-title: Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2011.01.023
– volume: 130
  start-page: 460
  year: 2004
  ident: 10.1016/j.clinre.2015.06.017_bib0220
  article-title: Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics
  publication-title: J Cancer Res Clin Oncol
  doi: 10.1007/s00432-004-0564-9
– volume: 72
  start-page: 4405
  year: 2012
  ident: 10.1016/j.clinre.2015.06.017_bib0205
  article-title: Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-0777
– volume: 71
  start-page: 4932
  year: 2011
  ident: 10.1016/j.clinre.2015.06.017_bib0190
  article-title: Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-10-4249
– volume: 7
  start-page: 1159
  year: 2011
  ident: 10.1016/j.clinre.2015.06.017_bib0230
  article-title: Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis
  publication-title: Autophagy
  doi: 10.4161/auto.7.10.16818
– volume: 345
  start-page: 486
  year: 2006
  ident: 10.1016/j.clinre.2015.06.017_bib0255
  article-title: Divergent expression and roles for caveolin-1 in mouse hepatocarcinoma cell lines with varying invasive ability
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2006.03.246
– volume: 18
  start-page: 3042
  year: 2012
  ident: 10.1016/j.clinre.2015.06.017_bib0250
  article-title: Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1alpha to promote hepatocellular carcinoma invasiveness
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-12-0183
– volume: 7
  start-page: 423
  year: 2012
  ident: 10.1016/j.clinre.2015.06.017_bib0275
  article-title: Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms
  publication-title: Annu Rev Pathol
  doi: 10.1146/annurev-pathol-011811-120856
– volume: 2
  start-page: 120
  year: 2012
  ident: 10.1016/j.clinre.2015.06.017_bib0160
  article-title: Caveolae, caveolins, cavins, and endothelial cell function: new insights
  publication-title: Front Physiol
  doi: 10.3389/fphys.2011.00120
– volume: 146
  start-page: 148
  year: 2011
  ident: 10.1016/j.clinre.2015.06.017_bib0290
  article-title: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis
  publication-title: Cell
  doi: 10.1016/j.cell.2011.05.040
– volume: 30
  start-page: 4498
  year: 2011
  ident: 10.1016/j.clinre.2015.06.017_bib0235
  article-title: IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer
  publication-title: Oncogene
  doi: 10.1038/onc.2011.154
– volume: 72
  start-page: 4097
  year: 2012
  ident: 10.1016/j.clinre.2015.06.017_bib0270
  article-title: Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-0448
– volume: 379
  start-page: 1245
  year: 2012
  ident: 10.1016/j.clinre.2015.06.017_bib0155
  article-title: Hepatocellular carcinoma
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)61347-0
– volume: 587
  start-page: 782
  year: 2013
  ident: 10.1016/j.clinre.2015.06.017_bib0195
  article-title: Caveolin-1 up-regulates integrin alpha2,6-sialylation to promote integrin alpha5beta1-dependent hepatocarcinoma cell adhesion
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2013.02.002
– volume: 29
  start-page: 977
  year: 2012
  ident: 10.1016/j.clinre.2015.06.017_bib0210
  article-title: Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer
  publication-title: Med Oncol
  doi: 10.1007/s12032-011-9900-5
– volume: 50
  start-page: 204
  year: 2014
  ident: 10.1016/j.clinre.2015.06.017_bib0170
  article-title: Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic condition
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2013.08.016
– volume: 73
  start-page: 1900
  year: 2013
  ident: 10.1016/j.clinre.2015.06.017_bib0175
  article-title: Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-3040
– volume: 273
  start-page: 117
  year: 2009
  ident: 10.1016/j.clinre.2015.06.017_bib0165
  article-title: The biology of caveolae: achievements and perspectives
  publication-title: Int Rev Cell Mol Biol
  doi: 10.1016/S1937-6448(08)01804-2
– volume: 42
  start-page: 438
  year: 2010
  ident: 10.1016/j.clinre.2015.06.017_bib0215
  article-title: Increased caveolin-1 expression associated with prolonged overall survival rate in hepatocellular carcinoma
  publication-title: Pathology
  doi: 10.3109/00313025.2010.494293
– volume: 226
  start-page: 645
  year: 2012
  ident: 10.1016/j.clinre.2015.06.017_bib0200
  article-title: Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis
  publication-title: J Pathol
  doi: 10.1002/path.3957
– volume: 25
  start-page: 2586
  year: 2007
  ident: 10.1016/j.clinre.2015.06.017_bib0240
  article-title: Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.09.4565
– volume: 9
  start-page: 65
  year: 2009
  ident: 10.1016/j.clinre.2015.06.017_bib0260
  article-title: Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-9-65
– volume: 366
  start-page: 1156
  year: 2012
  ident: 10.1016/j.clinre.2015.06.017_bib0265
  article-title: Tumor-cell death, autophagy, and immunity
  publication-title: N Engl J Med
  doi: 10.1056/NEJMcibr1114526
SSID ssj0000450871
Score 2.248162
Snippet Caveolin-1 is a member of the caveolae family of membrane proteins. Although some researchers have investigated the function of Caveolin-1 in hepatocellular...
Summary Background Caveolin-1 is a member of the caveolae family of membrane proteins. Although some researchers have investigated the function of Caveolin-1...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 169
SubjectTerms Autophagy - physiology
Carcinoma, Hepatocellular - metabolism
Carcinoma, Hepatocellular - pathology
Carcinoma, Hepatocellular - secondary
Caveolin 1 - biosynthesis
Caveolin 1 - physiology
Cell Proliferation
Female
Gastroenterology and Hepatology
Humans
Internal Medicine
Liver Neoplasms - metabolism
Liver Neoplasms - pathology
Male
Middle Aged
Prognosis
Tumor Cells, Cultured
Title Caveolin-1 promotes tumor growth and metastasis via autophagy inhibition in hepatocellular carcinoma
URI https://www.clinicalkey.com/#!/content/1-s2.0-S2210740115001539
https://www.clinicalkey.es/playcontent/1-s2.0-S2210740115001539
https://www.ncbi.nlm.nih.gov/pubmed/26206578
https://www.proquest.com/docview/1778707217
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaWIiEuiDfLS0bihrzKO9kjqqiqqnCAVtqbFTuTbip2U-0mPXDgd_BzmbGdR2lXBS5RlNjZjefLjGc08w1j7_0kDotU44cEWSKiaF4KNHpK5JCjhVC-B2CyLb4kh6fR0SJeTCa_RllLbaNm-seNdSX_I1W8hnKlKtl_kGz_ULyA5yhfPKKE8fhXMt7PL4Ga7gif8qxw0YmvoV3Vmw9n6F27orUVNDluAYl45JIqsFqiEshNvd-yUlWX7LhEu9TUFMc3iamaegyta6e1OyoDU0ZpWZ0dS9BymNuTOZ3h721qIvvcXAnaH1etSemDSnwdKtCOLIvBMVR9FKGyUVnKuBWLajTSBbcXlThww13Awk9GeS5GrwXoZQpqBGhN0Pia6Z7TK2bL4-QAGIy0rG-7u1zT_jYQcT6jotINcaD6sSFntdWhI0BcrAwiiIw_iW0LoT9Yt7tbd9jdAB0Q6o0x--n30TvcCHuZ8eb7t-nqMk3y4PV_QKzT7pm7tkC7XByz1Tl5yB44H4V_tIB7xCawfszufXZZGE9YMeCOd7jjBnfc4o4jCviAO4644z3u-IA7POVXccd73D1lpwefTvYPhevWIXSU-Y1QaBkSDVlRxvPMg0irMtJF4kGgUojLEopwnkFcaOWrwAMdopJAbyLKgmJe5KDCZ2xvXa_hBeNKl7lXxlAWqogA4hzdQJ3F4JWRl-ssmbKwW0CpHZU9dVT5LrucxXNpJSBJApJSN_10ykQ_68JSudwyPu5kI7syZTSsEtF2y7z0pnmwdZpjK325DaQnvxF2CDrolOH0cD5l7zoISNTytPT5GuoWZ6RkWNOAnv7cYqN_hw5WL3feecXuDx_ia7bXbFp4g3vpRr01sP4NFXvMIQ
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Caveolin-1+promotes+tumor+growth+and+metastasis+via+autophagy+inhibition+in+hepatocellular+carcinoma&rft.jtitle=Clinics+and+research+in+hepatology+and+gastroenterology&rft.au=Liu%2C+Wei-Ren&rft.au=Jin%2C+Lei&rft.au=Tian%2C+Meng-Xin&rft.au=Jiang%2C+Xi-Fei&rft.date=2016-04-01&rft.issn=2210-7401&rft.eissn=2210-741X&rft.volume=40&rft.issue=2&rft.spage=169&rft_id=info:doi/10.1016%2Fj.clinre.2015.06.017&rft_id=info%3Apmid%2F26206578&rft.externalDocID=26206578
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2210-7401&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2210-7401&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2210-7401&client=summon